A comparison of gut mycobiome of multiple sclerosis (MS) subjects with a healthy control group has identified correlations between specific mycobiome and the autoimmune disease.
Scientists have found that the state of the gut microbiome is often altered in those with chronic conditions, which has further spurred the popularity of probiotics to restore the gut microbiome. However, researchers from the University of Vermont (UVM)...
A new study in mice has concluded that a compound found in the peels of fruits such as apples and prunes, and some herbs, can reduce and even reverse damage to brain cells in patients with Multiple Sclerosis (MS).
High levels of vitamin D may be associated with reduced disease activity and a lower risk of progression for people with multiple sclerosis (MS), according to new research.
A single dose of calcitriol, the active hormone form of vitamin D, followed by ongoing vitamin D supplementation could help to halt the progression of multiple sclerosis, according to new research in mice.
Supplementation with omega-3 fatty acids has no benefit on the disease activity of multiple sclerosis, according to data from a new clinical trial the authors acknowledged was underpowered.
Supplements of vitamin D at ‘critical time periods’ may be key to reducing the risk of multiple sclerosis, according to a new study from the UK and Canada.
Higher levels of vitamin D in the body may reduce the risk of
developing the neurological disease multiple sclerosis by as much
as 62 per cent, Harvard researchers report.
Nascobal, the drug produced by Nastech Pharmaceutical and designed
to treat vitamin B12 deficiency, has been granted approval by the
FDA for use in the treatment of patients suffering from HIV, AIDS,
multiple sclerosis and Crohn's...
A compound found in the spice turmeric could help slow the
progression of the debilitating disease multiple sclerosis (MS),
according to preliminary studies on rats.
